From "clinical Proteomics" to "clinical Chemistry Proteomics": Considerations using quantitative mass-spectrometry as a model approach

Clinical Chemistry and Laboratory Medicine

Volumn 50, Issue 2, 2012, Pages 235-242

  Lehmann, Sylvain ^a   Poinot, Pauline ^b   Tiers, Laurent ^a   Junot, Christophe ^b   Becher, Franois ^b   Hirtz, Christophe ^a  

^a HÔPITAL SAINT ELOI   (France)

^b SERVICE DE CHIMIE BIOORGANIQUE ET DE MARQUAGE   (France)

Author keywords

absolute quantification; clinical chemistry; mass spectrometry; peptides and proteins

Indexed keywords

BIOLOGICAL MARKER;

CLINICAL CHEMISTRY; FOLLOW UP; HUMAN; IMMUNOASSAY; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; QUANTITATIVE ANALYSIS; REVIEW; VALIDATION PROCESS;

CHEMISTRY, CLINICAL; HUMANS; MASS SPECTROMETRY; MODELS, BIOLOGICAL; PROTEOMICS; TUMOR MARKERS, BIOLOGICAL;

EID: 84860533945     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm.2011.744     Document Type: Review

References (40)

1. IFCC, CLSI. Mass spectrometry in the clinical laboratory: general principles and guidance. Wayne, PA: IFCC, CLSI, 2010.
2. Carbonnelle E, Mesquita C, Bille E, Day N, Dauphin B, Beretti JL, et al. MALDI-TOF mass spectrometry tools for bacterial identification in clinical microbiology laboratory. Clin Biochem 2010;44:104-9.
3. van den Broek I, Sparidans RW, Schellens JH, Beijnen JH. Quantitative assay for six potential breast cancer biomarker peptides in human serum by liquid chromatography coupled to tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2010;878:590-602.
4. Kuzyk MA, Smith D, Yang J, Cross TJ, Jackson AM, Hardie DB, et al. Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma. Mol Cell Proteomics 2009;8:1860-77.
5. Roche S, Gabelle A, Lehmann S. Clinical proteomics of the cerebrospinal fluid: towards the discovery of new biomarkers. Proteomics: Clin Applic 2008;2:428-36. (Pubitemid 351425370)
6. Hortin GL, Sviridov D. The dynamic range problem in the analysis of the plasma proteome. J Proteomics 2011;73:629-36.
7. Barton C, Beck P, Kay R, Teale P, Roberts J. Multiplexed LC-MS/MS analysis of horse plasma proteins to study doping in sport. Proteomics 2009;9:3058-65.
8. Fortin T, Salvador A, Charrier JP, Lenz C, Lacoux X, Morla A, et al. Clinical quantitation of prostate-specific antigen biomarker in the low nanogram/milliliter range by conventional bore liquid chromatography-tandem mass spectrometry (multiple reaction monitoring) coupling and correlation with ELISA tests. Mol Cell Proteomics 2009;8:1006-15.
9. Ackermann BL, Berna MJ. Coupling immunoaffinity techniques with MS for quantitative analysis of low-abundance protein bio-markers. Expert Rev Proteomics 2007;4:175-86. (Pubitemid 46588454)
10. Kulasingam V, Diamandis EP. Strategies for discovering novel cancer biomarkers through utilization of emerging technologies. Nat Clin Pract Oncol 2008;5:588-99.
11. Whiteaker JR, Zhao L, Anderson L, Paulovich AG. An automated and multiplexed method for high throughput peptide immunoaf-finity enrichment and multiple reaction monitoring mass spec-trometry-based quantification of protein biomarkers. Mol Cell Proteomics 2009;9:184-96.
12. Koutroukides TA, Guest PC, Leweke FM, Bailey DM, Rahmoune H, Bahn S, et al. Characterization of the human serum depletome by label-free shotgun proteomics. J Sep Sci 2011;34:1621-6.
13. Roche S, Tiers L, Provansal M, Seveno M, Piva MT, Jouin P, et al. Depletion of one, six, twelve or twenty major blood proteins before proteomic analysis: The more the better? J Proteomics 2009;72:945-51.
14. Cao J, Gonzalez-Covarrubias V, Straubinger RM, Wang H, Duan X, Yu H, et al. A rapid, reproducible, on-the-fly orthogonal array optimization method for targeted protein quantification by LC/MS and its application for accurate and sensitive quan-tification of carbonyl reductases in human liver. Anal Chem 2010;82:2680-9.
15. Li N, Palandra J, Nemirovskiy OV, Lai Y. LC-MS/MS mediated absolute quantification and comparison of bile salt export pump and breast cancer resistance protein in livers and hepatocytes across species. Anal Chem 2009;81:2251-9.
16. Izrael-Tomasevic A, Phu L, Phung QT, Lill JR, Arnott D. Targeting interferon alpha subtypes in serum: a comparison of analytical approaches to the detection and quantitation of proteins in complex biological matrices. J Proteome Res 2009;8:3132-40.
17. Kuhn E, Addona T, Keshishian H, Burgess M, Mani DR, Lee RT, et al. Developing multiplexed assays for troponin I and inter-leukin-33 in plasma by peptide immunoaffinity enrichment and targeted mass spectrometry. Clin Chem 2009;55:1108-17.
18. Fortin T, Salvador A, Charrier JP, Lenz C, Bettsworth F, Lacoux X, et al. Multiple reaction monitoring cubed for protein quantifi-cation at the low nanogram/milliliter level in nondepleted human serum. Anal Chem 2009;81:9343-52.
19. Anderson NL, Anderson NG, Haines LR, Hardie DB, Olafson RW, Pearson TW. Mass spectrometric quantitation of peptides and proteins using Stable Isotope Standards and Capture by Anti-Peptide Antibodies (SISCAPA). J Proteome Res 2004;3:235-44. (Pubitemid 38500990)
20. Addona TA, Abbatiello SE, Schilling B, Skates SJ, Mani DR, Bunk DM, et al. Multi-site assessment of the precision and repro-ducibility of multiple reaction monitoring-based measurements of proteins in plasma. Nat Biotechnol 2009;27:633-41.
21. West-Norager M, Kelstrup CD, Schou C, Hogdall EV, Hogdall CK, Heegaard NH. Unravelling in vitro variables of major importance for the outcome of mass spectrometry-based serum proteomics. J Chromatogr B Analyt Technol Biomed Life Sci 2007;847:30-7. (Pubitemid 46216199)
22. Karsan A, Eigl BJ, Flibotte S, Gelmon K, Switzer P, Hassell P, et al. Analytical and preanalytical biases in serum pro-teomic pattern analysis for breast cancer diagnosis. Clin Chem 2005;51:1525-8. (Pubitemid 41060893)
23. Guder WG. Preanalytical factors and their influence on analytical quality specifications. Scand J Clin Lab Invest 1999;59:545-9. (Pubitemid 30056749)
24. Betsou F, Barnes R, Burke T, Coppola D, Desouza Y, Eliason J, et al. Human biospecimen research: experimental protocol and quality control tools. Cancer Epidemiol Biomarkers Prev 2009;18:1017-25.
25. Sillanaukee P, Lof K, Harlin A, Martensson O, Brandt R, Seppa K. Comparison of different methods for detecting carbohydrate-deficient transferrin. Alcohol Clin Exp Res 1994;18:1150-5. (Pubitemid 24345522)
26. Brewis IA, Brennan P. Proteomics technologies for the global identification and quantification of proteins. Adv Protein Chem Struct Biol 2010;80:1-44.
27. Bantscheff M, Schirle M, Sweetman G, Rick J, Kuster B. Quantitative mass spectrometry in proteomics: a critical review. Anal Bioanal Chem 2007;389:1017-31. (Pubitemid 47482251)
28. Voyksner RD, Lee H. Investigating the use of an octupole ion guide for ion storage and high-pass mass filtering to improve the quantitative performance of electrospray ion trap mass spectrom-etry. Rapid Commun Mass Spectrom 1999;13:1427-37. (Pubitemid 29345292)
29. Chelius D, Bondarenko P V. Quantitative profiling of proteins in complex mixtures using liquid chromatography and mass spectrometry. J Proteome Res 2002;1:317-23. (Pubitemid 36395872)
30. Bondarenko PV, Chelius D, Shaler TA. Identification and relative quantitation of protein mixtures by enzymatic digestion followed by capillary reversed-phase liquid chromatography-tandem mass spectrometry. Anal Chem 2002;74:4741-9.
31. Higgs RE, Knierman MD, Gelfanova V, Butler JP, Hale JE. Comprehensive label-free method for the relative quantifi-cation of proteins from biological samples. J Proteome Res 2005;4:1442-50. (Pubitemid 41208703)
32. Pan J, Chen HQ, Sun YH, Zhang JH, Luo XY. Comparative proteomic analysis of non-small-cell lung cancer and normal controls using serum label-free quantitative shotgun technology. Lung 2008;186:255-61.
33. Ackermann BL, Berna MJ, Murphy AT. Recent advances in use of LC/MS/MS for quantitative high-throughput bio analytical support of drug discovery. Curr Top Med Chem 2002;2: 53-66.
34. Bateman RJ, Munsell LY, Morris JC, Swarm R, Yarasheski KE, Holtzman DM. Human amyloid-beta synthesis and clearance rates as measured in cerebrospinal fluid in vivo. Nat Med 2006;12:856-61. (Pubitemid 44050079)
35. Siu KW, DeSouza LV, Scorilas A, Romaschin AD, Honey RJ, Stewart R, et al. Differential protein expressions in renal cell carcinoma: new biomarker discovery by mass spectrometry. J Proteome Res 2009;8:3797-807.
36. Brun V, Dupuis A, Adrait A, Marcellin M, Thomas D, Court M, et al. Isotope-labeled protein standards: toward absolute quantitative proteomics. Mol Cell Proteomics 2007;6:2139-49.
37. Janecki DJ, Bemis KG, Tegeler TJ, Sanghani PC, Zhai L, Hurley TD, et al. A multiple reaction monitoring method for absolute quantification of the human liver alcohol dehydrogenase ADH1C1 isoenzyme. Anal Biochem 2007;369:18-26. (Pubitemid 47313380)
38. Heudi O, Barteau S, Zimmer D, Schmidt J, Bill K, Lehmann N, et al. Towards absolute quantification of therapeutic monoclonal antibody in serum by LC-MS/MS using isotope-labeled antibody standard and protein cleavage isotope dilution mass spectrom-etry. Anal Chem 2008;80:4200-7. (Pubitemid 351812775)
39. Tang K, Page JS, Smith RD. Charge competition and the linear dynamic range of detection in electrospray ionization mass spectrometry. J Am Soc Mass Spectrom 2004;15:1416-23. (Pubitemid 39311692)
40. Lebert D, Dupuis A, Garin J, Bruley C, Brun V. Production and use of stable isotope-labeled proteins for absolute quantitative proteomics. Methods Mol Biol 2011;753:93-115.